Print

ANDA Litigation Settlements

Case Name Drug Patent No(s). Publicly Available Terms

Merck Sharp & Dohme Corp. Aurobindo Pharma. Ltd., 13-5442 (D.N.J.)

Sustiva® (efavirenz)

6,639,071
6,673,372
6,939,964

N/A

Noven Pharma. v. Watson Labs. Inc., 11-5997 (D.N.J.)

Daytrana® (methylphenidate transdermal system)

6,348,211

Noven will grant Shire PLC a nonexclusive, royalty-bearing license to market generic methylphenidate transdermal patches beginning in September 2015, or earlier under certain unspecified conditions.

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.